New Drug's first human test begins

NCT ID NCT07158437

Summary

This is the first time researchers are testing the experimental drug SL-325 in humans. The study will enroll 72 healthy volunteers to check if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo, and neither they nor the doctors will know which one they get.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Celerion

    RECRUITING

    Lincoln, Nebraska, 68502, United States

Conditions

Explore the condition pages connected to this study.